DADLE

DADLE (D-Ala2, D-Leu5-enkephalin) is a synthetic opioid peptide with analgesic properties. It is an enkephalin analog that selectively binds to the delta opioid receptor. DADLE has been studied for its potential neuroprotective effects and its role in modulating the body's response to stress and pain.

Structure and Function

DADLE is a pentapeptide, meaning it is composed of five amino acids. Its structure is D-Ala2, D-Leu5-enkephalin, which indicates that it contains D-alanine and D-leucine. The D-configuration of these amino acids is what allows DADLE to selectively bind to the delta opioid receptor.

The delta opioid receptor is one of three types of opioid receptors in the body, the others being the mu opioid receptor and the kappa opioid receptor. When DADLE binds to the delta opioid receptor, it can inhibit the release of certain neurotransmitters, leading to analgesic effects.

Clinical Significance

DADLE has been studied for its potential therapeutic applications, particularly in the field of neurology. Some research suggests that DADLE may have neuroprotective effects, meaning it could potentially be used to protect nerve cells from damage or degeneration.

In addition, DADLE has been shown to modulate the body's response to stress and pain. This could have implications for the treatment of conditions such as chronic pain and stress-related disorders.

Research and Future Directions

While DADLE has shown promise in preclinical studies, further research is needed to fully understand its mechanisms of action and potential therapeutic applications. Future studies may focus on exploring the effects of DADLE in animal models of disease, as well as investigating its safety and efficacy in human clinical trials.

See Also

• Opioid peptide
• Delta opioid receptor
• Enkephalin

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia

DADLE

• 
  2-D-Alanine-5-D-leucine-enkephalin